Related Experiment Video
Updated: Aug 15, 2026
09:07
Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis
Michael D Howell1, Natalija Novak, Thomas Bieber
1Division of Allergy and Immunology, Department of Pediatrics, The National Jewish Medical and Research Center, Denver, Colorado 80206, USA.
The Journal of Investigative Dermatology
|September 28, 2005
Summary
Atopic dermatitis (AD) patients show reduced antimicrobial peptide (AMP) expression due to increased interleukin-10 (IL-10). Blocking IL-10 in AD skin explants restored AMP levels, suggesting a new therapeutic target for skin infections.
Area of Science:
- Dermatology
- Immunology
- Molecular Biology
Background:
- Atopic dermatitis (AD) involves extrinsic (EAD) and intrinsic (IAD) subtypes, both prone to skin infections.
- While EAD is linked to IL-4/IL-13 suppressing antimicrobial peptides (AMPs), IAD's infection mechanism is unclear.
- Both AD subtypes exhibit decreased human beta-defensin (HBD)-2 and increased IL-10 gene expression compared to psoriasis.
Purpose of the Study:
- To investigate the mechanism of AMP deficiency in both EAD and IAD.
- To explore the role of IL-10 in regulating AMP expression in AD.
- To assess the potential of targeting IL-10 for therapeutic benefit.
Main Methods:
- Gene expression analysis of HBD-2 and IL-10 in skin lesions from AD patients and psoriasis controls.
- In vitro studies using primary keratinocytes to assess AMP expression defects.
- Experiments with neutralizing antibodies against IL-10 on peripheral blood mononuclear cells and skin explants from AD patients.
Main Results:
- Significantly decreased HBD-2 gene expression was observed in both IAD and EAD skin compared to psoriasis.
- Elevated IL-10 gene expression was found in IAD and EAD skin lesions versus psoriasis.
- IL-10 neutralization enhanced TNF-alpha and IFN-gamma production and restored HBD-2 and LL-37 expression in AD skin explants.
Conclusions:
- The deficiency in AMP expression in AD is an acquired defect, not constitutive.
- Elevated IL-10 levels contribute to AMP deficiency in both IAD and EAD by suppressing AMP-inducing cytokines.
- Targeting IL-10 may represent a novel therapeutic strategy to combat skin infections in atopic dermatitis.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...